Improving Universal Pediatric Lipid Screening

Objective To evaluate whether the release of national guidelines, electronic health record (EHR) modifications, and educational initiatives correlated with changes in pediatricians' universal lipid screening practices. Study design Retrospective review of EHRs in an academic general pediatric practice was performed to measure the prevalence of order placement. A child was “screened” if an order was placed during a well‐visit between 9 and 21 years of age. The prevalence of order placement for lipid screens on 22 374 patients from January 2010 to December 2015 was analyzed for date of order and patient age, then compared with timing of guidelines, local educational initiatives, and EHR modifications. Primary study outcome was lipid screening order placement over time. Results Order placement increased from 8.9% (95% CI 8.3%‐9.5%) before any intervention to 50.0% (95% CI 48.8%‐51.2%) over the last 12 months of the study period (P < .001). All age groups showed significant increases in order placement. Changes in screening were seen following guideline publications, educational initiatives, and EHR modifications (for all, P < .0001). Order completion was 69.6% (95% CI 68.9%‐70.3%). The composite prevalence of screening (order placement multiplied by order completion) was 46.8% over the 6‐year study period. Conclusions Improved adherence to recommendations for universal lipid screening is possible through educational initiatives and EHR modifications. Inclusion of 12‐ to 16‐year‐old adolescents/teenagers as a targeted group for universal screening in addition to recommended age groups improved screening prevalence. Similar efforts could be applicable for implementation of other guidelines.

[1]  J. Zachariah,et al.  Pediatric lipid management: an earlier approach. , 2014, Endocrinology and metabolism clinics of North America.

[2]  D. Labarthe,et al.  Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat! , 2009, American journal of preventive medicine.

[3]  H. Binns,et al.  Physicians’ Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening , 2015, Clinical pediatrics.

[4]  Catherine Boileau,et al.  Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease , 2013, European heart journal.

[5]  D. Wald,et al.  The evaluation of cascade testing for familial hypercholesterolemia , 2012, American journal of medical genetics. Part A.

[6]  J. Danesh,et al.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. , 2016, Journal of the American College of Cardiology.

[7]  Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group. , 1991, BMJ.

[8]  H. Büller,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[9]  S. D. de Ferranti,et al.  Cholesterol testing among children and adolescents during health visits. , 2014, JAMA.

[10]  S. Humphries,et al.  Child-Parent Familial Hypercholesterolemia Screening in Primary Care. , 2017, The New England journal of medicine.

[11]  W. Neal,et al.  Universal Versus Targeted Blood Cholesterol Screening Among Youth: The CARDIAC Project , 2010, Pediatrics.

[12]  G. Watts,et al.  Prevalence of Familial Hypercholesterolemia in Adolescents: Potential Value of Universal Screening? , 2016, The Journal of pediatrics.

[13]  Jennifer G. Robinson,et al.  Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. , 2011, Journal of clinical lipidology.

[14]  S. Daniels,et al.  Is universal pediatric lipid screening justified? , 2012, JAMA.

[15]  M. Pletcher,et al.  Overly Aggressive New Guidelines for Lipid Screening in Children: Evidence of a Broken Process , 2012, Pediatrics.

[16]  A. Rodday,et al.  Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) , 2016, Circulation.

[17]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[18]  M. Phipps,et al.  Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force Recommendation Statement , 2016 .

[19]  J. Steinberger,et al.  Implementation of lipid screening guidelines in children by primary pediatric providers. , 2014, The Journal of pediatrics.

[20]  J. Kastelein,et al.  Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[21]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2016, Pediatric Clinical Practice Guidelines & Policies.

[22]  S. Szpunar,et al.  Predictors of Screening for Hyperlipidemia in an Urban Pediatric Tertiary Care Center , 2015, Clinical pediatrics.